Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
- PMID: 20843905
- DOI: 10.3899/jrheum.100001
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
Abstract
Objective: Systemic sclerosis (SSc) is a rare connective tissue disease in childhood. We compared the characteristics of adult patients with juvenile-onset SSc (jSSc) from a single-center cohort to an adult-onset group.
Methods: Patients with disease onset before the age of 17 years were included in the jSSc cohort, while subjects with SSc onset after age 17 formed the adult-onset cohort.
Results: We identified 52 adult subjects with jSSc and compared them to 954 patients with adult-onset SSc. The mean ± SD age at disease onset of the patients with jSSc was 14 ± 2 years, 39 (75%) of them were women, and 24 (46%) had the diffuse cutaneous subset of SSc (dcSSc). There were no differences between the 2 cohorts in terms of sex and disease subset. Overlaps were significantly more frequent among the jSSc cohort (37%) compared to the adult-onset group (18%; p = 0.002). Autoantibody analysis demonstrated significantly more antitopoisomerase I antibody-positive subjects (33% vs 20%; p = 0.034) and significantly fewer anticentromere antibody-positive subjects (2% vs 25%; p < 0.001) in the jSSc cohort. Compared to the adult-onset group at 10 years from disease onset, survival was significantly higher among the subjects with jSSc (98% vs 75%; p = 0.001), pulmonary arterial hypertension had a significantly lower incidence (2% vs 14%; p = 0.032), and there was no difference in terms of pulmonary fibrosis (22% vs 21%) and cardiac scleroderma (3% vs 2%) between the 2 groups.
Conclusion: The high survival rates and lower proportion of dcSSc in the adult jSSc cohort may represent a survival bias.
Similar articles
-
Juvenile systemic sclerosis: report of three cases and review of Japanese published work.J Dermatol. 2007 Sep;34(9):658-61. doi: 10.1111/j.1346-8138.2007.00350.x. J Dermatol. 2007. PMID: 17727371 Review.
-
A case of juvenile systemic sclerosis with disease onset at six months old.Clin Rheumatol. 2003 May;22(2):162-3. doi: 10.1007/s10067-002-0678-x. Clin Rheumatol. 2003. PMID: 12740689
-
Juvenile systemic sclerosis: a follow-up study of eight patients.Ann N Y Acad Sci. 2005 Jun;1051:229-34. doi: 10.1196/annals.1361.063. Ann N Y Acad Sci. 2005. PMID: 16126963
-
Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.J Dermatol. 2010 Jan;37(1):42-53. doi: 10.1111/j.1346-8138.2009.00762.x. J Dermatol. 2010. PMID: 20175839 Review.
-
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.Arthritis Rheum. 2006 Dec;54(12):3971-8. doi: 10.1002/art.22207. Arthritis Rheum. 2006. PMID: 17133611
Cited by
-
Update on juvenile systemic sclerosis.Curr Rheumatol Rep. 2015 Mar;17(3):18. doi: 10.1007/s11926-014-0491-y. Curr Rheumatol Rep. 2015. PMID: 25761925 Review.
-
Immunopathogenesis of Juvenile Systemic Sclerosis.Front Immunol. 2019 Jun 25;10:1352. doi: 10.3389/fimmu.2019.01352. eCollection 2019. Front Immunol. 2019. PMID: 31293569 Free PMC article. Review.
-
Pediatric scleroderma: systemic or localized forms.Pediatr Clin North Am. 2012 Apr;59(2):381-405. doi: 10.1016/j.pcl.2012.03.011. Epub 2012 Apr 6. Pediatr Clin North Am. 2012. PMID: 22560576 Free PMC article. Review.
-
CAR T cell therapy for children with rheumatic disease: the time is now.Nat Rev Rheumatol. 2025 Aug;21(8):494-506. doi: 10.1038/s41584-025-01272-3. Epub 2025 Jul 2. Nat Rev Rheumatol. 2025. PMID: 40603629 Review.
-
Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.Arthritis Rheumatol. 2016 Nov;68(11):2772-2777. doi: 10.1002/art.39765. Epub 2016 Oct 6. Arthritis Rheumatol. 2016. PMID: 27214100 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical